부산대학교 도서관

Revue d'Histoire littéraire de la France, 1951 Jan 01. 51(3), 373-379.

Ajuria, L. Carril; Naigeon, M.; Flippot, R.; Dalban, C.; Desnoyer, A.; Rioux-Leclercq, N.; Sautes-Fridman, C.; Meylan, M.; Vano, Y.; Beuselinck, B.; Chouaib, S.; de Oliveira, C.; Tantot, F.; Escudier, B.; Chaput-Gras, N.; Albiges, L.

Immuno-Oncology and Technology. 20

Flippot, R.; Teixeira, M.; Roblin, E.; Ajuria, L. Carril; Naigeon, M.; Rainho, L.T.; Cassard, L.; Danlos, F-X.; Escudier, B.; Albiges, L.; Chaput-Gras, N.

Immuno-Oncology and Technology. 20

Naigeon, M.; Roulleaux Dugage, M.; Danlos, F-X.; De Oliveira, C.; Boselli, L.; Jouniaux, J-M.; Griscelli, F.; Marabelle, A.; Cassard, L.; Roman, G.; Hulett, T.; Besse, B.; Chaput-Gras, N.

Immuno-Oncology and Technology. 16

Carril-Ajuria L; Department of Medical Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, 94805, France.; Laboratory of Immunomonitoring in Oncology, CNRS UMS 3655, INSERM US23, Gustave Roussy, Paris-Saclay University, Villejuif, 94805, France.; Flippot R; Department of Medical Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, 94805, France.; Laboratory of Immunomonitoring in Oncology, CNRS UMS 3655, INSERM US23, Gustave Roussy, Paris-Saclay University, Villejuif, 94805, France.; Naigeon M; Laboratory of Immunomonitoring in Oncology, CNRS UMS 3655, INSERM US23, Gustave Roussy, Paris-Saclay University, Villejuif, 94805, France.; Paris-Saclay University, UFR Pharmacy, Orsay, France.; Dalban C; Centre Leon Bernard, Lyon, France.; Desnoyer A; Laboratory of Immunomonitoring in Oncology, CNRS UMS 3655, INSERM US23, Gustave Roussy, Paris-Saclay University, Villejuif, 94805, France.; Rioux-Leclercq N; Service Anatomie et Cytologie Pathologiques, CHU, Université de Rennes, Paris, France.; Sautès-Fridman C; Cordeliers Research Center, Paris, France.; Meylan M; Cordeliers Research Center, Paris, France.; Vano YA; Service d'Oncologie Médicale, Hôpital Européen Georges Pompidou, Paris, France.; Beuselinck B; General Medical Oncology, University Hospitals Leuven, Belgique, Europe.; Chouaib S; Inserm U1186, Immunologie Integrative et Oncogenetique, Institute Gustave Roussy, Villejuif, France.; de Oliveira C; Laboratory of Immunomonitoring in Oncology, CNRS UMS 3655, INSERM US23, Gustave Roussy, Paris-Saclay University, Villejuif, 94805, France.; Tantot F; GETUG group, Unicancer, Paris, France.; Rainho L; Department of Medical Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, 94805, France.; Escudier B; Department of Medical Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, 94805, France.; Albiges L; Department of Medical Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, 94805, France.; Chaput N; Laboratory of Immunomonitoring in Oncology, CNRS UMS 3655, INSERM US23, Gustave Roussy, Paris-Saclay University, Villejuif, 94805, France.; Paris-Saclay University, UFR Pharmacy, Orsay, France.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Charrier, M. ; Mezquita, L. ; Lueza, B. ; Dupraz, L. ; Planchard, D. ; Remon, J. ; Caramella, C. ; Cassard, L. ; Boselli, L. ; Reiners, K.S. ; Pogge von Strandmann, E. ; Rusakiewicz, S. ; Ferrara, R. ; Duchemann, B. ; Naigeon, M. ; Pignon, J.P. ; Besse, B. ; Chaput, N.

In European Journal of Cancer February 2019 108:88-96

Auclin E; Medical Oncology Department, Hôpital Européen Georges Pompidou, AP-HP, France; Institut Bergonié, Bordeaux, France.; Roulleaux Dugage M; Medical Oncology Department, Hôpital Européen Georges Pompidou, AP-HP, France; Drug Development Department, Institut Gustave Roussy, Villejuif, France.; Gorria T; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain; Laboratory of Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.; Vauchier C; Medical Oncology Department, Hôpital Européen Georges Pompidou, AP-HP, France; Institut Bergonié, Bordeaux, France.; Thibault C; Medical Oncology Department, Hôpital Européen Georges Pompidou, AP-HP, France; Institut Bergonié, Bordeaux, France.; Laguna JC; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain; Laboratory of Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.; Lupinacci L; Medical Oncology Department, Hospital Italiano, Buenos Aires, Argentina.; Crous C; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona, Spain.; Naigeon M; Faculté de Pharmacie, Université Paris Saclay, Orsay, France; Immunomonitoring Laboratory, CNRS3655 and INSERM US23, Université Paris-Saclay, Villejuif, France.; Oudard S; Medical Oncology Department, Hôpital Européen Georges Pompidou, AP-HP, France; Institut Bergonié, Bordeaux, France.; Besse B; Department of Medicine, Institut Gustave Roussy, Villejuif, France.; Mezquita L; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain; Laboratory of Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain. Electronic address: lmezquita@clinic.cat.

Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Filippo G. Dall’Olio; Wael Zrafi; Veronique Roelants; Valentina Ambrosini; Aloyse Fourquet; Cristina Mitea; Francesco Passiglia; Matteo Bauckneht; Gerald Bonardel; Nicole Conci; Jose Carlos Benitez; Vincenzo Arena; Céline Namour; Marie Naigeon; Isabelle Monnet; Kristi Beshiri; Delphine Hoton; Safiye Dursun; François Xavier Danlos; Giulia Argalia; Mihaela Aldea; Guido Rovera; Lisa Derosa; Valerio Iebba; Hester A. Gietema; Valerie Gounant; Valérie Lacroix; Jordi Remon; Daniel Gautheret; Nathalie Chaput; Bastien Job; Patricia L. Kannouche; Monica Velasco-Nuño; Laurence Zitvogel; Eugenia Cella; José Reinaldo Chícharo de Freitas; Damien Vasseur; Mohamed Aymen Bettaieb; Marco Tagliamento; Lizza Hendriks; Antoine Italiano; David Planchard; Aurelien Marabelle; Fabrice Barlesi; Silvia Novello; Desiree De Andreis; Frank Aboubakar Nana; Andrea Ardizzoni; Gerard Zalcman; Camilo Garcia; Benjamin Besse

Clinical Cancer Research, Vol. /, no./, p. / (2024)

Ajuria, L. Carril; Naigeon, M.; Dalban, C.; Desnoyer, A.; Rioux-Leclercq, N.; Sautes-Fridman, C.; Meylan, M.; Vano, Y.; Beuselinck, B.; Chouaib, S.; de Oliveira, C.; Tantot, Olivier; Escudier, B.; Albiges, L.; Chaput, N.

Lécuyer D; Université Paris-Saclay, Inserm UMR1030, Laboratory of Molecular Radiotherapy and Therapeutic Innovation, Villejuif, France.; Gustave Roussy Cancer Center, Villejuif, France.; Nardacci R; National Institute for Infectious Diseases 'Lazzaro Spallanzani', Rome, Italy.; UniCamillus - Saint Camillus International University of Health and Medical Sciences, Rome, Italy.; Tannous D; Université Paris-Saclay, Inserm UMR1030, Laboratory of Molecular Radiotherapy and Therapeutic Innovation, Villejuif, France.; Gustave Roussy Cancer Center, Villejuif, France.; NH TherAguix SAS, Meylan, France.; Gutierrez-Mateyron E; Université Paris-Saclay, Inserm UMR1030, Laboratory of Molecular Radiotherapy and Therapeutic Innovation, Villejuif, France.; Gustave Roussy Cancer Center, Villejuif, France.; Deva Nathan A; Université Paris-Saclay, Inserm UMR1030, Laboratory of Molecular Radiotherapy and Therapeutic Innovation, Villejuif, France.; Gustave Roussy Cancer Center, Villejuif, France.; Subra F; Université Paris-Saclay, ENS Paris-Saclay, CNRS UMR 8113, IDA FR3242, Laboratory of Biology and Applied Pharmacology (LBPA), Gif-sur-Yvette, France.; Di Primio C; Institute of Neuroscience, Italian National Research Council, Pisa, Italy.; Laboratory of Biology BIO@SNS, Scuola Normale Superiore, Pisa, Italy.; Quaranta P; Institute of Neuroscience, Italian National Research Council, Pisa, Italy.; Retrovirus Center, Department of Translational Research, Universita of Pisa, Pisa, Italy.; Petit V; Université Paris-Saclay, Inserm U1274, CEA, Genetic Stability, Stem Cells and Radiation, Fontenay-aux-Roses, France.; Richetta C; Université Paris-Saclay, ENS Paris-Saclay, CNRS UMR 8113, IDA FR3242, Laboratory of Biology and Applied Pharmacology (LBPA), Gif-sur-Yvette, France.; Mostefa-Kara A; Université Paris-Saclay, Inserm UMR1030, Laboratory of Molecular Radiotherapy and Therapeutic Innovation, Villejuif, France.; Gustave Roussy Cancer Center, Villejuif, France.; Del Nonno F; National Institute for Infectious Diseases 'Lazzaro Spallanzani', Rome, Italy.; Falasca L; National Institute for Infectious Diseases 'Lazzaro Spallanzani', Rome, Italy.; Marlin R; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA- HB/IDMIT), Fontenay-aux-Roses, France.; Maisonnasse P; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA- HB/IDMIT), Fontenay-aux-Roses, France.; Delahousse J; Université Paris-Saclay, Inserm UMR1030, Laboratory of Molecular Radiotherapy and Therapeutic Innovation, Villejuif, France.; Gustave Roussy Cancer Center, Villejuif, France.; Pascaud J; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA- HB/IDMIT), Fontenay-aux-Roses, France.; Assistance Publique, Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, Le Kremlin Bicêtre, France.; Deprez E; Université Paris-Saclay, ENS Paris-Saclay, CNRS UMR 8113, IDA FR3242, Laboratory of Biology and Applied Pharmacology (LBPA), Gif-sur-Yvette, France.; Naigeon M; Gustave Roussy Cancer Center, Villejuif, France.; Université Paris-Saclay, Inserm, CNRS, Analyse Moléculaire, Modélisation et Imagerie de la Maladie Cancéreuse, Laboratoire d'Immunomonitoring en Oncologie, Villejuif, France.; Université Paris-Saclay, Faculté de Pharmacie, Chatenay-Malabry, France.; Chaput N; Université Paris-Saclay, Inserm, CNRS, Analyse Moléculaire, Modélisation et Imagerie de la Maladie Cancéreuse, Laboratoire d'Immunomonitoring en Oncologie, Villejuif, France.; Université Paris-Saclay, Faculté de Pharmacie, Chatenay-Malabry, France.; Université Paris-Saclay, Gustave Roussy Cancer Center, CNRS, Stabilité Génétique et Oncogenèse, Villejuif, France.; Paci A; Université Paris-Saclay, Inserm UMR1030, Laboratory of Molecular Radiotherapy and Therapeutic Innovation, Villejuif, France.; Gustave Roussy Cancer Center, Villejuif, France.; Université Paris-Saclay, Faculté de Pharmacie, Chatenay-Malabry, France.; Department of Biology and Pathology, Gustave Roussy Cancer Center, Villejuif, France.; Saada V; Department of Biology and Pathology, Gustave Roussy Cancer Center, Villejuif, France.; Ghez D; Université Paris-Saclay, Inserm UMR1030, Laboratory of Molecular Radiotherapy and Therapeutic Innovation, Villejuif, France.; Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France.; Mariette X; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA- HB/IDMIT), Fontenay-aux-Roses, France.; Assistance Publique, Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, Le Kremlin Bicêtre, France.; Université Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France.; Costa M; Institute of Neuroscience, Italian National Research Council, Pisa, Italy.; Laboratory of Biology BIO@SNS, Scuola Normale Superiore, Pisa, Italy.; Centro Pisano Ricerca e Implementazione Clinical Flash Radiotherapy 'CPFR@CISUP', 'S. Chiara' Hospital, Pisa, Italy.; Pistello M; Retrovirus Center, Department of Translational Research, Universita of Pisa, Pisa, Italy.; Virology Operative Unit, Pisa University Hospital, Pisa, Italy.; Allouch A; Université Paris-Saclay, Inserm UMR1030, Laboratory of Molecular Radiotherapy and Therapeutic Innovation, Villejuif, France.; Gustave Roussy Cancer Center, Villejuif, France.; NH TherAguix SAS, Meylan, France.; Delelis O; Université Paris-Saclay, ENS Paris-Saclay, CNRS UMR 8113, IDA FR3242, Laboratory of Biology and Applied Pharmacology (LBPA), Gif-sur-Yvette, France.; Piacentini M; National Institute for Infectious Diseases 'Lazzaro Spallanzani', Rome, Italy.; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.; Le Grand R; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA- HB/IDMIT), Fontenay-aux-Roses, France.; Perfettini JL; Université Paris-Saclay, Inserm UMR1030, Laboratory of Molecular Radiotherapy and Therapeutic Innovation, Villejuif, France.; Gustave Roussy Cancer Center, Villejuif, France.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Naigeon M; INSERM US23/CNRS UAR 3655, Laboratoire d'Immunomonitoring en Oncologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Bitoun S; Rheumatology Department, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1184, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris (APHP), CEA, FHU CARE, Université Paris-Saclay, Le Kremlin Bicêtre, France.; Roulleaux Dugage M; INSERM US23/CNRS UAR 3655, Laboratoire d'Immunomonitoring en Oncologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif, France.; de Oliveira C; INSERM US23/CNRS UAR 3655, Laboratoire d'Immunomonitoring en Oncologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Berthot C; INSERM US23/CNRS UAR 3655, Laboratoire d'Immunomonitoring en Oncologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Besse B; Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France.; Marabelle A; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Danlos FX; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Mariette X; Rheumatology Department, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1184, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris (APHP), CEA, FHU CARE, Université Paris-Saclay, Le Kremlin Bicêtre, France.; Chaput N; INSERM US23/CNRS UAR 3655, Laboratoire d'Immunomonitoring en Oncologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Nocturne G; Rheumatology Department, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1184, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris (APHP), CEA, FHU CARE, Université Paris-Saclay, Le Kremlin Bicêtre, France.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE

Baldini, C. ; Rodriguez, J.E. ; Roulleaux Dugage, M. ; Massard, C.P. ; Jouniaux, J-M. ; Naigeon, M. ; Girard, L. ; Besse, B. ; Baptiste Micol, J. ; Marabelle, A. ; Cassard, L. ; Danlos, F-X. ; Marzac, C. ; Chaput-Gras, N.

In Annals of Oncology September 2025 36 Supplement 2:S915-S915

Ferrara, R.; Naigeon, M.; Auclin, E.; Duchemann, B.; Cassard, L.; Medhi, J.J.; Boselli, L.; Grivel, J.; Desnoyer, A.; Texier, M.; Mezquita, L.; Aboubakar Nana, Frank; Hendriks, L.; Planchard, D.; Caramella, C.; Remon, J.; Ngocamus, M.; Nicotra, C.; Proto, C.; Sangaletti, S.; Chaput, N.; Besse, B.; IASLC 2019 World Conference on Lung Cancer

Journal of Thoracic Oncology, Vol. 14, no.10, p. S452 (2019)

Michot JM; Département des Innovations Thérapeutiques et des Essais Précoces (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif 94800, France.; Dozio V; Biognosys, Wagistrasse 21, Schlieren 8952, Switzerland.; Rohmer J; Service de Médecine Interne, Hôpital Foch, Suresnes 92150, France.; Pommeret F; Département de Médecine, Gustave Roussy, Université Paris-Saclay, Villejuif 94800, France.; Roumier M; Service de Médecine Interne, Hôpital Foch, Suresnes 92150, France.; Yu H; Biognosys, Wagistrasse 21, Schlieren 8952, Switzerland.; Sklodowki K; Biognosys, Wagistrasse 21, Schlieren 8952, Switzerland.; Danlos FX; Département de Médecine, Gustave Roussy, Université Paris-Saclay, Villejuif 94800, France.; Ouali K; Département de Médecine, Gustave Roussy, Université Paris-Saclay, Villejuif 94800, France.; Kishazi E; Biognosys, Wagistrasse 21, Schlieren 8952, Switzerland.; Naigeon M; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif 94800, France.; Laboratoire d'Immunomonitoring en Oncologie, Gustave Roussy, Université Paris-Saclay, Villejuif 94800, France.; Université Paris Saclay, Faculté de Pharmacie, Chatenay-Malabry F-92296, France.; Griscelli F; Département de biologie et pathologie, Gustave Roussy Cancer Campus, Villejuif 94800, France.; Gachot B; Unité de Pathologie Infectieuse, Gustave Roussy Cancer Campus, Villejuif 94800, France.; Groh M; Service de Médecine Interne, Hôpital Foch, Suresnes 92150, France.; Bacciarello G; Département de Médecine, Gustave Roussy, Université Paris-Saclay, Villejuif 94800, France.; Stoclin A; Unité de Pathologie Infectieuse, Gustave Roussy Cancer Campus, Villejuif 94800, France.; Willekens C; Département d'hématologie, Gustave Roussy Cancer Campus, Villejuif 94800, France.; Sakkal M; Département des Innovations Thérapeutiques et des Essais Précoces (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif 94800, France.; Bayle A; Département des Innovations Thérapeutiques et des Essais Précoces (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif 94800, France.; Zitvogel L; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif 94800, France.; Silvin A; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif 94800, France.; Soria JC; Département des Innovations Thérapeutiques et des Essais Précoces (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif 94800, France.; Université Paris Saclay, Faculté de Médecine, Le Kremlin-Bicêtre 94270, France.; Barlesi F; Département de Médecine, Gustave Roussy, Université Paris-Saclay, Villejuif 94800, France.; Beeler K; Biognosys, Wagistrasse 21, Schlieren 8952, Switzerland.; André F; Département de Médecine, Gustave Roussy, Université Paris-Saclay, Villejuif 94800, France.; Université Paris Saclay, Faculté de Médecine, Le Kremlin-Bicêtre 94270, France.; Unité INSERM U981, Gustave Roussy Cancer Campus, Villejuif 94800, France.; Vasse M; Université Paris Saclay, Faculté de Pharmacie, Chatenay-Malabry F-92296, France.; Service de biologie clinique, Hôpital Foch, Suresnes 92150, France.; Unité INSERM U1176, Le Kremlin-Bicêtre, Université Paris Saclay, Faculté de Médecine, Le Kremlin-Bicêtre 94270, France.; Chaput N; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif 94800, France.; Laboratoire d'Immunomonitoring en Oncologie, Gustave Roussy, Université Paris-Saclay, Villejuif 94800, France.; Ackermann F; Service de Médecine Interne, Hôpital Foch, Suresnes 92150, France.; Escher C; Biognosys, Wagistrasse 21, Schlieren 8952, Switzerland.; Marabelle A; Département des Innovations Thérapeutiques et des Essais Précoces (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif 94800, France.; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif 94800, France.; Université Paris Saclay, Faculté de Médecine, Le Kremlin-Bicêtre 94270, France.; Centre d'investigation clinique - biothérapie, INSERM CICBT1428, Villejuif 94800, France.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 101128775 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-3907 (Electronic) Linking ISSN: 15353893 NLM ISO Abbreviation: J Proteome Res Subsets: MEDLINE

Ferrara, R.; Naigeon, M.; Auclin, E.; Duchemann, B.; Cassard, L.; Medhi, J.; Boselli, L.; Grivel, J.; Desnoyer, A.; Mezquita, L.; Aboubakar Nana, Frank; Hendriks, L.; Planchard, D.; Caramella, C.; Remon, J.; Ngocamus, M.; Nicotra, C.; Besse, B.; Chaput, N.; IASLC 19th World Conference on Lung Cancer

Journal of Thoracic Oncology, Vol. 13, no.10, p. S466-S467 (2018)

Flippot R; Department of Medical Oncology, Gustave Roussy, Université Paris Saclay, Villejuif, France RONAN.FLIPPOT@gustaveroussy.fr.; Immunomonitoring Laboratory, CNRS3655 & INSERM US23, Université Paris-Saclay, Villejuif, France.; Teixeira M; Department of Medical Oncology, Gustave Roussy, Université Paris Saclay, Villejuif, France.; Immunomonitoring Laboratory, CNRS3655 & INSERM US23, Université Paris-Saclay, Villejuif, France.; Rey-Cardenas M; Department of Medical Oncology, Gustave Roussy, Université Paris Saclay, Villejuif, France.; Immunomonitoring Laboratory, CNRS3655 & INSERM US23, Université Paris-Saclay, Villejuif, France.; Carril-Ajuria L; Department of Medical Oncology, Gustave Roussy, Université Paris Saclay, Villejuif, France.; Immunomonitoring Laboratory, CNRS3655 & INSERM US23, Université Paris-Saclay, Villejuif, France.; Medical Oncology, CHU Brugmann, Brussels, Belgium.; Rainho L; Department of Medical Oncology, Gustave Roussy, Université Paris Saclay, Villejuif, France.; Immunomonitoring Laboratory, CNRS3655 & INSERM US23, Université Paris-Saclay, Villejuif, France.; Naoun N; Department of Medical Oncology, Gustave Roussy, Université Paris Saclay, Villejuif, France.; Jouniaux JM; Immunomonitoring Laboratory, CNRS3655 & INSERM US23, Université Paris-Saclay, Villejuif, France.; Boselli L; Immunomonitoring Laboratory, CNRS3655 & INSERM US23, Université Paris-Saclay, Villejuif, France.; Naigeon M; Immunomonitoring Laboratory, CNRS3655 & INSERM US23, Université Paris-Saclay, Villejuif, France.; Danlos FX; LRTI, INSERM U1015, Gustave Roussy, Villejuif, France.; Drug Development Department, Gustave Roussy, Villejuif, France.; Escudier B; Department of Medical Oncology, Gustave Roussy, Université Paris Saclay, Villejuif, France.; Scoazec JY; Pathology, Gustave Roussy, Villejuif, France.; Cassard L; Immunomonitoring Laboratory, CNRS3655 & INSERM US23, Université Paris-Saclay, Villejuif, France.; Albiges L; Department of Medical Oncology, Gustave Roussy, Université Paris Saclay, Villejuif, France.; Immunomonitoring Laboratory, CNRS3655 & INSERM US23, Université Paris-Saclay, Villejuif, France.; Chaput N; Immunomonitoring Laboratory, CNRS3655 & INSERM US23, Université Paris-Saclay, Villejuif, France.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Mourey L; IUCT-Oncopole Claudius Regaud, Toulouse, France.; Rainho LT; Department of Cancer Medicine, Gustave Roussy, Paris Saclay University, Villejuif, France.; Dalban C; Leon Berard Center, University Lyon I, Lyon, France.; Carril-Ajuria L; Department of Cancer Medicine, Gustave Roussy, Paris Saclay University, Villejuif, France.; Negrier S; Leon Berard Center, University Lyon I, Lyon, France.; Chevreau C; IUCT-Oncopole Claudius Regaud, Toulouse, France.; Gravis G; Institut Paoli-Calmettes, Department of Medical Oncology, Aix Marseille Univ, INSERM, CNRS, CRCM, Immunity and Cancer Team, Marseille, France.; Thibault C; Hopital Européen Georges Pompidou, Paris, France.; Laguerre B; Centre Eugène Marquis, Rennes, France.; Barthelemy P; Institut de Cancérologie Strasbourg Europe, Strasbourg, France.; Borchiellini D; Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France.; Gross-Goupil M; Department of Medical Oncology, Centre Hospitalier Universitaire Saint-André, Bordeaux, France.; Geoffrois L; Institut de Cancérologie de Lorraine, Vandoeuvre-Lès-Nancy, France.; Rolland F; Institut de Cancérologie de l'Ouest, Nantes, France.; Thiery-Vuillemin A; University Hospital Jean Minjoz, Besançon, France.; Tantot F; UNICANCER, Kremlin Bicetre, France.; Chaput N; Immunomonitoring Laboratory, UMS CNRS3655 & INSERM US23, Gustave Roussy, Paris Saclay University, Villejuif, France.; Naigeon M; Immunomonitoring Laboratory, UMS CNRS3655 & INSERM US23, Gustave Roussy, Paris Saclay University, Villejuif, France.; Teixeira M; Department of Cancer Medicine, Gustave Roussy, Paris Saclay University, Villejuif, France.; Escudier B; Department of Cancer Medicine, Gustave Roussy, Paris Saclay University, Villejuif, France.; Flippot R; Department of Cancer Medicine, Gustave Roussy, Paris Saclay University, Villejuif, France; Immunomonitoring Laboratory, UMS CNRS3655 & INSERM US23, Gustave Roussy, Paris Saclay University, Villejuif, France.; Albiges L; Department of Cancer Medicine, Gustave Roussy, Paris Saclay University, Villejuif, France; Immunomonitoring Laboratory, UMS CNRS3655 & INSERM US23, Gustave Roussy, Paris Saclay University, Villejuif, France. Electronic address: laurence.albiges@gustaveroussy.fr.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Bitoun, S. ; Naigeon, M. ; Roulleaux-Dugage, M. ; DE Oliveira, C. ; Berthot, C. ; Mariette, X. ; Chaput-Gras, N. ; Nocturne, G.

In Annals of the Rheumatic Diseases June 2024 83 Supplement 1:1127-1127

Lasvergnas J; Medical and Thoracic Oncology Department, Hopital Avicenne, AP-HP, Bobigny, France.; Faculty of Medicine, University of Paris, Paris, France.; Naigeon M; Gustave Roussy Cancer Campus, Laboratory of Immunomonitoring in Oncology, CNRS-UMS 3655, INSERM-US23, Villejuif, France.; Faculty of Pharmacy, University Paris-Saclay, Chatenay-Malabry, France.; Faculty of Medicine, University Paris-Saclay, Le Kremlin Bicêtre, France.; Chouahnia K; Medical and Thoracic Oncology Department, Hopital Avicenne, AP-HP, Bobigny, France.; Zelek L; Medical and Thoracic Oncology Department, Hopital Avicenne, AP-HP, Bobigny, France.; Chaput N; Gustave Roussy Cancer Campus, Laboratory of Immunomonitoring in Oncology, CNRS-UMS 3655, INSERM-US23, Villejuif, France.; Faculty of Pharmacy, University Paris-Saclay, Chatenay-Malabry, France.; Duchemann B; Medical and Thoracic Oncology Department, Hopital Avicenne, AP-HP, Bobigny, France. boris.duchemann@aphp.fr.; Gustave Roussy Cancer Campus, Laboratory of Immunomonitoring in Oncology, CNRS-UMS 3655, INSERM-US23, Villejuif, France. boris.duchemann@aphp.fr.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Benitez, J. C.; Sanchez-Becerra, M. V.; Chaput, N.; Naigeon, M.; Cassard, L.; Girard, L.; Korera, D.; Cozic, N.; Lavaud, P.; Abdayem, P.; Albarragan-Artahona, V.; Botticella, A.; Planchard, D.; Remon, J.; Barlesi, F.; Le Pechoux, C.; Besse, B.; Levy, A.

JOURNAL OF THORACIC ONCOLOGY; OCT 2024, 19 10, pS179-pS180, 2p. Supplement: S